Robertet acquires a stake in cosmetic ingredient supplier Aethera Biotech

The French specialist in natural raw materials for perfumery, cosmetics, and aromas deepens its collaboration with the Italian biotechnology company by investing in a joint venture.

With this strengthened relationship, Robertet hopes to strengthen its position in the cosmetic active ingredients industry. The goal of this first step in biotech is to combine Aethera Biotech's technologies—its intellectual property, production capabilities, and existing product line—with Robertet's global commercial reach.

Aethera Biotech, founded in 2016, focuses on the study, development, and production of active substances derived from the cell multiplication process. Aethera Biotech, a subsidiary of the Italian family-owned firm Cereal Docks, is a leader in phyto-complex biotechnologies. Inspired by natural plant mechanisms, this technique allows for the safe manufacturing of natural extracts in regulated settings, regardless of meteorological, agricultural, or geopolitical constraints, while drastically lowering environmental effect. Aethera Biotech, headquartered in Camisano Vicentino, employs a team of 25 specialists with complementary skills in all biotech operations, from R&D to industrialisation.

Aethera Biotech will become Robertet's center of excellence for future biotech discoveries within the Group, allowing the company to join the market for topical cosmetic active ingredients with a distinct and distinctive offering.

"This joint venture underlines our belief that biotechnology will become increasingly crucial in the creation of high-value, long-term solutions. It complements our objective to strengthen our leadership in naturals while offering up new avenues for innovation and growth for our clients', says Jérôme Bruhat, CEO of Robertet.

"After nearly two years of close collaboration, this next step further advances our vision of Augmented Naturality," says Olivier Maubert, Group Innovation Director and Head of the Health & Beauty business at Robertet.

Robertet's progressive investment in the joint venture will be completed in two stages over a three-year period, subject to certain circumstances.

Source: Premium Beauty Media